John Temperato, Chief Executive Officer at 9 METERS BIOPHARMA, INC. (NMTR), bought 50,000 shares at $0.45 ($23K) on 2022-05-18, disclosed to the SEC on 2022-05-19.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| NMTR | BUY | 2021-11-19 | $53K | — | Filing → |
| NMTR | BUY | 2021-08-19 | $26K | — | Filing → |
| NMTR | BUY | 2021-04-06 | $100K | — | Filing → |